Community Awareness, Resources and Education (CARE II): Project 3

Completed

Conditions studied: Uterine Cervical Cancer

In brief

Researchers at The Ohio State University and the University of Michigan are working together to understand cancer of the cervix. One of the areas they are studying is how stress you may experience in your life effects the way you respond to GARDASIL®. GARDASIL® is a vaccine approved by the Food and Drug Administration (FDA) to prevent some types of Human Papillomavirus (HPV) infection which can cause cancer of the cervix. Participants are being recruited from the Appalachian region of Ohio.

Key facts

Study ID
NCT01299714
Run by
Ohio State University Comprehensive Cancer Center
People needed
191
Starts
2011-02-01
Expected to finish
2015-04-01
Last updated by the study team
2018-04-25

Who can join

Age: 18 and older, up to 26. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.